drugset / Trial / NCT00050674

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

NCT00050674 ↗

Phase 2 Completed 40 enrolled Schwartzberg, Lee, M.D. Amgen · collab
NaSingle-groupOpen-labelTreatment

Summary

Determine whether patients have a decreased incidence of grade 3 and grade 4 neutropenia when Filgrastim-SD/01 is given with docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.

Timeline

Start
2001-11
Primary completion
2007-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Filgrastim-SD/01 Unknown 6 mg Subcutaneous